Caribou Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $41.1M |
| Jun 2020 | — | — | $33.1M |
| Sep 2020 | — | — | $24.5M |
| Dec 2020 | $18.2M | $36.0M | $16.0M |
| Mar 2021 | — | — | $145.9M |
| Jun 2021 | $55.9M | $158.4M | $129.5M |
| Sep 2021 | $57.6M | $462.0M | $435.3M |
| Dec 2021 | $54.5M | $442.4M | $240.4M |
| Mar 2022 | $74.2M | $446.0M | $147.6M |
| Jun 2022 | $73.5M | $421.4M | $112.1M |
| Sep 2022 | $74.7M | $398.8M | $82.1M |
| Dec 2022 | $72.9M | $373.8M | $58.3M |
| Mar 2023 | $69.2M | $347.5M | $52.7M |
| Jun 2023 | $80.2M | $349.6M | $66.2M |
| Sep 2023 | $59.3M | $457.5M | $104.1M |
| Dec 2023 | $63.8M | $432.2M | $51.2M |
| Mar 2024 | $63.5M | $406.8M | $49.4M |
| Jun 2024 | $62.5M | $372.9M | $37.9M |
| Sep 2024 | $63.1M | $344.3M | $32.0M |
| Dec 2024 | $60.4M | $313.3M | $16.3M |
| Mar 2025 | $56.4M | $273.7M | $29.4M |
| Jun 2025 | $54.8M | $220.9M | $25.2M |
| Sep 2025 | $53.1M | $195.0M | $11.1M |
| Dec 2025 | $53.2M | $175.4M | $12.4M |
| Mar 2026 | $47.0M | $149.0M | $12.1M |
| Jun 2026 | $44.7M | $142.8M | $26.2M |